ClinicalTrials.govpublic full text
Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women
respiratory syncytial virus infections
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 332815
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.